Cost-Effectiveness of Nivolumab in Combination With Ipilimumab in First-Line Treatment of Advanced Melanoma in Sweden
Value in Health - United Kingdom
doi 10.1016/j.jval.2016.09.2200
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2016
Authors
Publisher
Elsevier BV